Wen Huang

Sichuan University

H指数:18

被引数:938

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intraoperative positioning strategies to improve stone-free outcomes during retrograde intrarenal surgery: a systematic review and meta-analysis

术中定位策略以提高后腹腔镜肾盂成形术的无石率：一项系统评价和Meta分析

World Journal of Urology

IF2.9

2026-09-280

PRE

FYN, a Novel Target of Fragile X Mental Retardation Protein, Potentially Underlies ERK1/2 Hyperactivation in Fragile X Syndrome

FYN，脆性X智力障碍蛋白的新型靶点，可能介导脆性X综合征中的ERK1/2过度激活

Molecular Neurobiology

IF4.3

2026-08-050

PRE

Yin-Huang-Qing-Fei-Capsule derived diosgenin and its optimized nanoconjugate target STAT3 against pulmonary fibrosis

银黄清肺胶囊衍生的薯蓣皂苷及其优化的纳米缀合物靶向STAT3治疗肺纤维化

Phytomedicine

IF8.3

2026-07-010

PRE

Correlation of Cerebrospinal Fluid and Serum Markers with EDSS-Assessed Baseline Disability in Multiple Sclerosis Patients

脑脊液和血清标志物与多发性硬化患者EDSS评估基线残疾的相关性

Multiple Sclerosis and Related Disorders

IF2.9

2026-05-290

OAAI

Evaluation of blood-brain barrier integrity and clinical characteristics in autoimmune glial fibrillary acidic protein astrocytopathy

Multiple Sclerosis and Related Disorders

IF2.9

2026-01-150

PRE

FcRn inhibition with efgartigimod ameliorates muscle weakness and modulates dendritic cell subsets in an experimental autoimmune myasthenia gravis mouse model

Efgartigimod介导的FcRn抑制可改善实验性自身免疫性重症肌无力小鼠模型的肌肉无力，并调节树突状细胞亚群。

International Immunopharmacology

IF4.7

2025-07-030

The characteristics of new-onset myasthenia gravis after COVID-19 outbreak: a cross-sectional study

COVID-19爆发后新发重症肌无力的特征：一项横断面研究

VIROLOGY JOURNAL

IF3.8

2025-05-130

The P38MAPK Pathway Mediates the Destruction of the Blood-Brain Barrier in Anti-NMDAR Encephalitis Mice

NEUROCHEMICAL RESEARCH

IF3.8

2024-11-190

OAAI

Proteomic Characterization Identifies Clinically Relevant Subgroups of Gastrointestinal Stromal Tumors

GASTROENTEROLOGY

IF25.1

2024-03-010

Clinical Characteristics of Myasthenia Gravis Patients with COVID-19 in Guangxi, China: A Case-Control Study

inflammation research

IF4.1

2023-07-012

Inhibiting PI3K/Akt-Signaling Pathway Improves Neurobehavior Changes in Anti-NMDAR Encephalitis Mice by Ameliorating Blood-Brain Barrier Disruption and Neuronal Damage

CELLULAR AND MOLECULAR NEUROBIOLOGY

IF4.8

2023-06-1414

OAAI

NMDA mediates disruption of blood-brain barrier permeability via Rho/ROCK signaling pathway

NEUROCHEMISTRY INTERNATIONAL

IF4

2022-03-0113

PRE

N-methyl-D-aspartic acid increases tight junction protein destruction in brain endothelial cell via caveolin-1-associated ERK1/2 signaling

TOXICOLOGY

IF4.6

2022-03-019

OAAI

A patient with granulomatous amoebic encephalitis caused by Balamuthia mandrillaris survived with two excisions and medication

BMC INFECTIOUS DISEASES

IF3

2022-01-159

OAAI

Rho-kinase inhibitor hydroxyfasudil protects against HIV-1 Tat-induced dysfunction of tight junction and neprilysin/Aβ transfer receptor expression in mouse brain microvessels

MOLECULAR AND CELLULAR BIOCHEMISTRY

IF3.7

2021-02-0614

OAAI

Rosiglitazone suppresses HIV-1 Tat-induced vascular inflammation via Akt signaling

MOLECULAR AND CELLULAR BIOCHEMISTRY

IF3.7

2015-06-0612

PREAI

PPAR agonist-mediated protection against HIV Tat-induced cerebrovascular toxicity is enhanced in MMP-9-deficient mice

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

IF4.5

2014-01-1548

OAAI

Hypoxia induces connexin 43 dysregulation by modulating matrix metalloproteinases via MAPK signaling

MOLECULAR AND CELLULAR BIOCHEMISTRY

IF3.7

2013-09-0449

OAAI

PPARα and PPARγ protect against HIV-1-induced MMP-9 overexpression via caveolae-associated ERK and Akt signaling

FASEB JOURNAL

IF4.2

2011-08-1246

OAAI

PPARα and PPARγ attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities

FASEB JOURNAL

IF4.2

2009-01-13115

OAAI

Wen Huang

个人简介

教育背景

工作经历

荣誉奖项

研究方向